PhaseBio Pharmaceuticals Inc
PHASDelisted Dec 21, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001169245
PhaseBio Pharmaceuticals Inc was delisted on Dec 21, 2022; its insiders filed their last Form 4 on May 19, 2023; 39 institutions reported holding it in 13F filings for Q3 2022, worth $3.90M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding PhaseBio Pharmaceuticals Inc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 52 | 57 | +5 |
| Shares | 28.2M | 29.4M | +1.26M (+4.5%) |
| Value | $73.5M | $38.8M | −$34.7M (−47.2%) |
New holders (11)
Institutions that held PhaseBio Pharmaceuticals Inc at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| MAI Capital Management | 1,418,279 | $1.87M | 0.03% |
| Towercrest Capital Management | 1,051,940 | $1.39M | 0.27% |
| Vericrest Private Wealth | 1,051,940 | $1.39M | 1.44% |
| Renaissance Technologies LLC | 89,300 | $118.0K | 0.00% |
| Virtu Financial LLC | 31,305 | $41.0K | 0.00% |
| United Bank | 26,900 | $36.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 25,500 | $34.0K | 0.00% |
| Two Sigma Securities, LLC | 21,479 | $28.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 20,143 | $27.0K | 0.00% |
| Curi Capital | 4,070 | $5.00K | 0.00% |
| Capital Advisory Group Advisory Services, LLC | 2,800 | $4.00K | 0.00% |
Sold out (6)
Institutions that held PhaseBio Pharmaceuticals Inc at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| ExodusPoint Capital Management, LP | 394,211 | $1.03M |
| Susquehanna International Group, LLP | 273,100 | $713.0K |
| Citadel Advisors LLC | 37,452 | $98.0K |
| XTX Topco Ltd | 15,574 | $41.0K |
| D. E. Shaw & Co., Inc. | 11,796 | $31.0K |
| Sargent Investment Group, LLC | 11,675 | $30.0K |